SCHEMBL9952599

SCHEMBL9952599

COc1cnc2c(c1)c(C(=O)C(=O)Nc1ccnc(OC)c1)c(C)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.59
RECQL P46063 1/20 0.40
CNR1 P21554 1/20 0.36
PPARG P37231 2/20 0.36
PLA2G2A P14555 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
MAPT P10636 3/20 0.35
TP53 P04637 3/20 0.35
P2RX7 Q99572 1/20 0.35
ANO1 Q5XXA6 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
JAK2 O60674 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
USP2 O75604 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9959066 0.90 FAAH (0.72) FAAHCNR1PLA2G2AMAPTALDH1A1
SCHEMBL9959161 0.89 FAAH (0.57) FAAHCNR1PPARGPLA2G2ASCN10A
SCHEMBL9959314 0.88 FAAH (0.59) FAAHCNR1SCN10AMAPTANO1
SCHEMBL2160399 0.88 FAAH (0.71) FAAHRECQLPLA2G2AMAPTALDH1A1
SCHEMBL2227880 0.85 FAAH (0.68) FAAHRECQLCNR1MAPTSMN1; SMN2
SCHEMBL2167660 0.85 FAAH (0.81) FAAHRECQLCNR1PLA2G2ASCN10A
SCHEMBL17970235 0.84 FAAH (0.53) FAAHCNR1PPARGPLA2G2ASCN10A
SCHEMBL10235139 0.84 FAAH (0.55) FAAHCNR1PPARGPLA2G2ASCN10A
SCHEMBL9958535 0.84 FAAH (0.54) FAAHPPARGPLA2G2ASCN10AMAPT
SCHEMBL9960923 0.84 FAAH (0.78) FAAHCNR1SCN10AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
EP-2655356-B1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS INC (US) 2016-08-03 EP disclosed
EP-2655356-B1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS INC (US) 2016-08-03 EP disclosed
US-20150175599-A1 FAAH Inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2015-06-25 US disclosed
WO-2014004676-A1 USE OF FAAH INHIBITORS AS NEUROPROTECTIVE AGENTS IN THE CNS IRONWOOD PHARMACEUTICALS, INC. (US) 2014-01-03 WO disclosed
EP-2655356-A1 FAAH INHIBITORS Ironwood Pharmaceuticals, Inc. (US) 2013-10-30 EP disclosed
WO-2012088469-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-06-28 WO disclosed
WO-2012088469-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175599-A1 FAAH Inhibitors FAAH, FAAH2, ASAH1 FAAH 1/4885RECQL 1280/4885CNR1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.